News

Centessa Pharmaceuticals Shares Exciting Phase 1 Data for ORX750

Centessa Pharmaceuticals Shares Exciting Phase 1 Data for ORX750

Exciting Developments from Centessa Pharmaceuticals

In an exciting announcement, Centessa Pharmaceuticals plc (NASDAQ: CNTA), a clinical-stage pharmaceutical company, has disclosed that it will present data from the Phase 1 clinical trial of its investigational drug, ORX750. This drug is an innovative orexin receptor 2 (OX2R) agonist that shows promise in treating various sleep-wake disorders, including narcolepsy type 1 (NT1) and narcolepsy type 2 (NT2).

Overview of the Upcoming Presentation

The Phase 1 clinical trial data will be shared in a poster presentation at the upcoming American Academy of Neurology (AAN) 2025 Annual Meeting, scheduled to take place from April 5-9, 2025. Centessa's commitment to advancing treatments for sleep-related conditions is underscored by their rigorous research and development efforts in this area.

Details of the Presentation

During this poster session, Centessa will provide an overview of the Phase 1 clinical data regarding ORX750. This novel compound is characterized as a highly potent and selective OX2R agonist, designed to aid patients suffering from NT1, NT2, and idiopathic hypersomnia (IH). The presentation, highlighting key findings and insights from the study, is anticipated to garner significant attention from the neuroscientific community.

Poster Presentation Details:

Title: Phase 1 Clinical Data with Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Participants
Abstract Number: 2277
Presenter: Deborah Hartman, PhD, Global Scientific Head, Orexin Program
Session Date and Time: Saturday, April 5, 2025, at 11:45 AM - 12:45 PM PT

Importance of ORX750

ORX750 stands out in Centessa's pipeline due to its targeted approach to mitigating the challenges faced by individuals suffering from significant sleep disturbances. The potential applications of this compound extend beyond merely treating narcolepsy; it is also being investigated for its effectiveness against excessive daytime sleepiness that often accompanies neurological and psychiatric conditions.

Current Trials and Future Directions

Currently, Centessa is advancing ORX750 through an ongoing Phase 2a clinical trial, referred to as CRYSTAL-1, which focuses on participants diagnosed with NT1, NT2, and IH. This research aims to elucidate the safety, tolerability, and efficacy of the drug, providing a solid foundation for subsequent studies and further development.

Centessa Pharmaceuticals continues to explore the vast potential of orexin receptor 2 (OX2R) agonists, seeking to create best-in-class treatments that significantly enhance patients' lives. They are also investigating other applications, including addressing symptoms like cognitive deficits, fatigue, and impaired attention.

Company Overview

Centessa Pharmaceuticals plc is on a mission to discover and develop transformative therapies for patients. Their commitment to advancing innovative treatments is evident in their robust portfolio focused on sleep-wake disorders and immuno-oncology. Through their proprietary LockBody technology platform, they are exploring new frontiers in cancer therapy as well.

Contact Information

For more information about Centessa Pharmaceuticals and their ongoing projects, please reach out to Kristen K. Sheppard, Esq., Senior Vice President of Investor Relations at investors@centessa.com.

Frequently Asked Questions

What is ORX750?

ORX750 is a novel orexin receptor 2 (OX2R) agonist being researched for the treatment of sleep-wake disorders, including narcolepsy types 1 and 2, and idiopathic hypersomnia.

Where will the Phase 1 data be presented?

The data will be showcased at the American Academy of Neurology (AAN) 2025 Annual Meeting in San Diego.

Who is presenting the ORX750 data?

The data will be presented by Deborah Hartman, PhD, who is the Global Scientific Head of the Orexin Program at Centessa.

What potential conditions could ORX750 help treat?

ORX750 has potential applications in treating narcolepsy, excessive daytime sleepiness, and possibly other sleep-related or cognitive symptoms.

How can I stay updated on Centessa Pharmaceuticals' research?

You can subscribe to their updates and reach out via email or check their website for the latest news and developments.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Agiloft Navigates New Growth Phase with Key Leadership

Updated Category News Views 174

Leadership Shifts Steer Agiloft's EMEA Journey Agiloft's latest shake-ups in leadership signal a determined charge through EMEA's bustling markets. Nick Bowles, a seasoned veteran in enterprise software, steps into the limelight as Senior Vice President, while Jim Leason shifts gears into a customer-focused advisory role. These aren’t just routine hiring...

Continue Reading
TagMaster To Acquire Kapsch's RFID Ops in NA Market

Updated Category News Views 91

A Strategic Move in the Transportation Sector Here's a fresh shake-up for the North American transportation sector: TagMaster, alongside its U.S. subsidiary Sensys Networks, is all set to acquire Kapsch TrafficCom's RFID-focused North American components business. This isn't just a minor shuffle—this deal could ripple through the industry, promising strategic uplifts...

Continue Reading
Aluminum Fluoride Market to Hit $3.3B by 2031

Updated Category News Views 150

Eye on the Aluminum Fluoride Surge Cracking open the numbers, the aluminum fluoride market is projected to swell from $2.48 billion in 2026 to a hefty $3.30 billion by 2031, trucking along at a CAGR of 5.9%. That's no small potatoes in the world of industrial materials. Scratch the surface, and you’ll see what's fueling this climb—think of it as a bellwether for...

Continue Reading
JardogsHealth Taps Industry Titans for Growth Council

Updated Category News Views 140

JardogsHealth: A New Chapter with Strategic Insights You've got to admire when a company rounds up a top-tier brain trust. Such is the case with JardogsHealth, the healthcare AI outfit nestled in Hillsboro, Illinois, as they align their future alongside heavyweights who’ve maneuvered through multiple industries and come out thriving. Their brand-new council includes...

Continue Reading
Understanding Septic Tank Pumping: Insights & Tips

Updated Category News Views 98

Why in the world are we discussing septic tanks today? Well, it’s because folks often overlook their importance until they’re knee-deep in unexpected plumbing woes. If you're a homeowner, understanding your septic system's needs is crucial to avoid literal and financial messes down the line. Behind the Scenes of Your Septic System Picture your household water usage....

Continue Reading
Health Net Invests $3 Million in Stockton Housing

Updated Category News Views 87

Putting a Roof Over Stockton's Head The talk of the town in Stockton is Health Net stepping up with a $3 million investment. This isn't just dropping loose change in a jar; it's about tackling a mammoth issue—making affordable housing more than just a pipe dream for 75 families. Community-driven, they say. What a cozy way to paint a picture of bridging that brutal gap...

Continue Reading
Where Winds Meet Celebrates 1st Anniversary With New Region

Updated Category News Views 73

A Staggering Universe Deepens: Hutuo's Introduction Just when you think you've seen it all, NetEase Games and Everstone Studio go and launch Hutuo, a compelling addition to the already sprawling universe of Where Winds Meet. On the occasion of its first global anniversary, this epic Wuxia ARPG throws players into the mud-soaked, steel-clashing chaos of a warzone, testing...

Continue Reading
Odessa Water Overbilling Lawsuit Surges Ahead

Updated Category News Views 181

Full Steam Ahead for Odessa's Water Fight Odessa, a dust-blown Texas town, ain't giving up without a fight. The court just lit a fire under the efforts of 46,000 residents and businesses hollering about their water bills that seemed to skyrocket outta nowhere. This court ruling lets the class action against the City of Odessa and Performance Services—they're the folks...

Continue Reading
AI Use Hits 93% in Health Systems' Digital Shift

Updated Category News Views 53

Healthcare's AI Surge: Jumping the Adoption Hurdle The digital health landscape isn't just humming along—it's hitting high gear. AI, once the shiny toy in innovation's toolkit, is now a fixture in 93.2% of healthcare systems according to CHIME's latest findings. For anyone keeping score, that's a hefty leap and paints a picture where AI isn't just in the game, it's...

Continue Reading
Sports Clock Radio: A Game Time Enthusiast's Dream

Updated Category News Views 87

A New Gadget for the Diehard Fan Fanatics, gather 'round. There's an innovation rolling out that's looking to marry the good old alarm clock radio with the rush of game day fever! Over in Pittsburgh, an inventor's cooking up something that every loyal sports fan might soon find irresistible—a Sports Clock Radio, bringing the stadium experience to your living room or...

Continue Reading

Top 5 Most Recently Viewed Articles

Mike Reynolds Elevates National Park Foundation Efforts

Updated Category News Views 50

Seasoned Leadership for National Park Foundation Well, here's a shakeup you don't see every day: Mike Reynolds, with more than four decades under his belt at the National Park Service (NPS), is now steering the ship over at the National Park Foundation (NPF) as their Chief Program Officer. In the nonprofit game, leadership's half the battle, and this veteran's set to roll...

Continue Reading
CM Seven Star Acquisition Faces Significant Challenges and Losses

Updated Category News Views 159

CM Seven Star Acquisition Corporation’s Stock Decline CM Seven Star Acquisition Corporation (NASDAQ: KXIN) has faced an incredibly challenging year, marked by significant stock price declines, with its shares recently hitting a 52-week low of $2.26. This steep drop of 97.96% demonstrates the company’s overwhelming struggles in a volatile market, reflecting broader...

Continue Reading
OpenText Wins 2025 SAP Pinnacle Award for Excellence in Solutions

Updated Category News Views 370

OpenText Achieves Recognition with the 2025 SAP Pinnacle Award OpenText has recently been celebrated for its exceptional performance as an SAP partner by receiving the prestigious 2025 SAP Pinnacle Award in the Partner Solution Success category. This award is a testament to OpenText’s sustained commitment to delivering top-quality solutions that help businesses maximize...

Continue Reading
Copper Supply Disruption Raises Prices Amid Market Volatility

Updated Category News Views 254

Copper Market Faces Uncertain Future The copper market is currently undergoing a significant shake-up due to unexpected disruptions at the Grasberg mine in Indonesia. These disturbances are causing ripples across supply forecasts and price expectations, leading to heightened concerns in the industry. Grasberg Mine Disruptions The operator at Grasberg has declared force...

Continue Reading
Faraday Future Intelligent Electric Stock Sees Notable Rise

Updated Category News Views 111

Faraday Future Intelligent Electric Stock Update Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) shares are experiencing a notable increase as the company has announced a significant acquisition. The latest development involves receiving a 10% stake in Grow Fandor, which has positively influenced investor sentiment. Details of the Recent Acquisition The stake in...

Continue Reading